Govt Job: For M.Pharm or MSc for Senior Research Fellow at CARI

The research institute, established in the year 1973 and renamed Central Ayurveda Research Institute in Dec 2020, is engaged in research with the focus mandate, conduct medicine-botanical exploration in parts of Central India.

Collect and supply genuine raw drug materials for R&D work To build up repositories for medicinal plants and crude drugs.

To establish an herbal garden and carry out the cultivation of medicinal plants for Ayurveda.

Post: Senior Research Fellow

A walk-in interview for 04 posts of Senior Research Fellow (SRF) Chemistry will be held at Central Ayurveda Research Institute, Jhansi.

A postgraduate degree in Chemistry or Chemical Sciences is required, as well as 2 years of experience. M.Pharma (Pharmaceutical Chemistry) from a reputable university or institution

Desirable: Preference will be given to candidates having experience in ASU&H drugs analysis including handling instruments like HPTLC/ HPLC/ LC-MS/ GC-MS/ ICPOES etc. and Publications in SCI Indexing Journals with article writing skills.

Preclinical Standardization and Development of SOP for Coated Tablets from Amlaki, Guduchi, and Vasa Aqueous and Hydroalcoholic Extracts, as well as Shelf-life Studies.”

Duration: One (1) Year

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

Effect of geographical variations, phytochemical profiling, and marker-based quantification of selected medicinally important Ficus species

Duration: Two (2) Years

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

QC Analysis, Estimation of Markers/PRS & Shelf-life Studies of Ayush PTK and Go-Mutra Haritaki

Duration : Three and a Half (3.5) Years

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

Development of Quality Standards, Estimation of Markers, and Shelf-Life Study of Ayush-82 and Ayush-SG

Duration: Three (3) Years

Age: Not exceeding 35 years as of 01.01.2022.

Pay : Rs. 35000 + HRA (18%)

General Terms and Conditions:
1. The engagement would be strictly contractual in nature and would run concurrently with the project; no claim for continuation of regular appointments will be considered.

2. The eligibility of candidates in respect of age will be determined as of 01.01.2022 & Relaxation in age for SC/ST/OBC etc. candidates as per Govt, of India Rules.

3. No TAD A will be paid for attending the interview.

Walk-in-Interview: 09.11.2022 at 9.30 AM onwards at Central Ayurveda Research Institute, Jhansi

Related Posts

Baby dies in Haryana’s Hisar as family’s 15-hour search for ventilator fails

HISAR: A newborn gasped to death as his family desperately went from hospital to hospital, looking for a ventilator, for 15 hours between Wednesday and Thursday. The tragedy raises questions…

Doctor, nurse removed after 2 maternal deaths in Jodhpur

Jodhpur: A new mother died Friday after being referred from the Govt Sub-District Hospital in Bhopalgarh to Ummed Hospital in Jodhpur district headquarters following complications during childbirth, prompting the medical…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Baby dies in Haryana’s Hisar as family’s 15-hour search for ventilator fails

Baby dies in Haryana’s Hisar as family’s 15-hour search for ventilator fails

Doctor, nurse removed after 2 maternal deaths in Jodhpur

Doctor, nurse removed after 2 maternal deaths in Jodhpur

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Aster Quality Care all set to make Advanced Healthcare Ubiquitous in India

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Rajasthan Bans Common Anaesthesia Injection Batch Used In Caesarean Deliveries And Surgeries: What Patients Need To Know

Raj orders statewide inspection of blood centres for compliance with safety norms

Raj orders statewide inspection of blood centres for compliance with safety norms

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review

mRNA Vaccines Proven Safe And Highly Effective Against Severe Infectious Diseases, Finds Lancet Review